Korean J Ophthalmol > Volume 37(1); 2023 > Article
Choi and Woo: Radiation Retinopathy after Heavy Ion Particle Therapy for Maxillary Sinus Cancer: A Case Report
Dear Editor,
Radiation retinopathy (RR) is a delayed obstructive microvascular retinopathy that usually develops months to years after radiation therapy and has characteristic findings, such as intraretinal hemorrhage, cotton wool patches, and capillary nonperfusion. Heavy ion particle therapy (HIPT) has emerged as a new technology owing to its safety. Currently, few cases of RR after HIPT have been reported in Japan [1]. Here, we report the first case of RR after HIPT in South Korea. This report was approved by the Institutional Review Board of Seoul National University Bundang Hospital (No. B-2208-774-706) and the patient provided written informed consent for publication of this case report.
A 37-year-old male patient visited the clinic for evaluation of his eye 1 month after receiving a total dose of 70.4 Gy carbon HIPT over 16 fractions in an area that included the optic nerve for undifferentiated polymorphic sarcoma in the right maxillary sinus. Brain and orbital magnetic resonance imaging (MRI) revealed that the tumor was in contact with the medial and inferior rectus muscles but did not invade the eyeball or optic nerve. Dendritic cell-based cancer vaccine treatment was concurrently combined with HIPT. Corrected visual acuity of 20 / 16 in the right eye was measured, and no abnormalities were found in the anterior segment and fundus.
After 23 months of HIPT, the corrected visual acuity was 20 / 125 in the right eye. Relative afferent pupillary defect and optic disc pallor were present in the right eye. Although atrophy or inflammation of the optic nerve was not confirmed by MRI, circumferential peripheral visual field defect was present. These were signs of optic neuropathy. Fluorescein angiography and optical coherence tomography (OCT) angiography were performed. There was no retinal neovascularization, but extensive nonperfusion of the peripheral retina including the macular area with multiple intraretinal hemorrhages and cotton wool patches was observed in the right eye (Fig. 1A-1D). Since the choroidal and retinal perfusion times were within normal range, diseases that induce perfusion abnormalities, such as retinal artery occlusion or ocular ischemic syndrome were excluded. Panretinal photocoagulation was performed to prevent neovascular complications.
After 33 months of HIPT, the visual-evoked potential revealed decreased P100 amplitude in the right eye which could be explained by both RR and radiation optic neuropathy. Panretinal photocoagulation was additionally performed because of iris neovascularization. After 3 months, the intraocular pressure increased to 24 mmHg with worsening of iris neovascularization in the right eye. Under the diagnosis of neovascular glaucoma, the intraocular pressure-lowering drugs were prescribed. Additionally, intravitreal bevacizumab (Avastin, Roche) was administered to the right eye five times every few months.
After 59 months of HIPT, cataract surgery was performed in the right eye for an intumescent cataract (Fig. 1E). Even after cataract surgery, the patient was unable to sense light with the right eye. Slit-lamp examination showed no iris neovascularization. On funduscopic examination, severe optic disc atrophy was observed (Fig. 1F). OCT showed overall retinal thinning and disruption in the right eye (Fig. 1G).
Recently, HIPT has been widely used in multiple periorbital cancer for its advantage of “Bragg peak” and “high relative biological effectiveness.” Bragg peak is a feature of particle radiation, delivering its maximum radiation dose to the tumor and minimizing damage to surrounding normal tissue [2]. With the Bragg peak, the occurrence of RR would be low with particle therapy; a previous study confirmed the superiority of particle therapy for RR occurrence [3]. Furthermore, the high relative biological effectiveness of HIPT compared to other radiation therapies enables less radiation to destroy the tumor [4].
Risk factors for the development of RR include total radiation dose and fraction size. The incidence of RR was previously reported to be 50% with 60 Gy total irradiation [5]. Sulaiman et al. [1] reported the incidence of RR after carbon HIPT with total irradiation dose of 64 Gy for head and neck cancer in 26 fractions to be 5%. In our patient, the carbon HIPT was performed at a total dose of 70.4 Gy. Despite the Bragg peak phenomenon, this patient experienced extensive vascular obstructive retinopathy and radiation optic neuropathy indicating that a high total dose of radiation with the involvement of the optic nerve in HIPT could surpass the Bragg peak effect. Therefore, the RR cascade should not be ignored in cases of a large total dose of radiation or when the radiation area is close to the retina or optic nerve for HIPT, despite its advantage of the Bragg peak and high relative biological effectiveness.




Conflicts of Interest: Se Joon Woo is a member of the Editorial Board of the Korean Journal of Ophthalmology since 2020. However, he was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Funding: This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korea government (the Ministry of Science and ICT) (No. 2020R1F1A1072795). The funding organization had no role in the design or conduct of this study.


1. Sulaiman NS, Demizu Y, Koto M, et al. Multicenter study of carbon-ion radiation therapy for adenoid cystic carcinoma of the head and neck: subanalysis of the Japan Carbon- Ion Radiation Oncology Study Group (J-CROS) study (1402 HN). Int J Radiat Oncol Biol Phys 2018;100:639-46.
crossref pmid
2. Elsasser T, Weyrather WK, Friedrich T, et al. Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. Int J Radiat Oncol Biol Phys 2010;78:1177-83.
crossref pmid
3. Wang Z, Nabhan M, Schild SE, et al. Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 2013;86:18-26.
crossref pmid
4. Mohan R, Grosshans D. Proton therapy: present and future. Adv Drug Deliv Rev 2017;109:26-44.
crossref pmid pmc
5. Merriam GR, Szechter A, Focht EF. The effects of ionizing radiations on the eye. In : Vaeth JM. In: Radiation effects and tolerance, normal tissue. In: Proceedings of the 6th Annual San Francisco Cancer Symposium; 1970 Oct; San Francisco, USA: Karger; 1972;pp 346-85.

Fig. 1
Clinical manifestations of the patient with radiation retinopathy after heavy ion particle therapy. (A) Ultra-wide field fundus photography, (B) fluorescein angiography, and (C,D) optical coherence tomography angiography of the right eye 23 months after particle therapy showing extensive nonperfused retina with multiple intraretinal hemorrhages and cotton wool patches as well as multiple patchy defects in the superficial and deep retinal capillary plexus in the posterior pole. The optical coherence tomography angiography of (C) superficial and (D) deep retinal capillary plexus. (E) The anterior segment photograph of the right eye 57 months after particle therapy shows an intumescent cataract. (F) Ultra-wide field fundus photography and (G) optical coherence tomography (vertical cut) of the right eye after cataract surgery revealed severe optic disc atrophy and retinal thinning.
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 1,019 View
  • 44 Download
Related articles

Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next